Characterization of primary and restenotic atherosclerotic plaque from the superficial femoral artery

Potential role of Smad3 in regulation of SMC proliferation

Rachel S. Edlin, Shirling Tsai, Dai Yamanouchi, Chunjie Wang, Bo Liu, K. Craig Kent

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Objective: To characterize and compare primary and restenotic lesions of the superficial femoral artery and analyze the contribution of TGF-β/Smad3 signaling to the pathophysiology of peripheral artery occlusive disease. Methods and Results: Immunohistochemical studies were performed on specimens retrieved from the superficial femoral artery of patients undergoing either atherectomy for primary atherosclerotic or recurrent disease after stenting and/or prior angioplasty. Immunohistochemical analysis revealed a significantly higher smooth muscle cell (SMC) content (α-actin+) and expression of Smad3 in restenotic lesions while primary lesions contained significantly more leukocytes (CD45+) and macrophages (CD68+). Further studies demonstrated colocalization of Smad3 with α-actin and PCNA, suggesting a role for Smad3 in the proliferation observed in restenotic lesions. To confirm a role for Smad3 in SMC proliferation, we both upregulated Smad3 via adenoviral mediated gene transfer (AdSmad3) and inhibited Smad3 through transfection with siRNA in human aortic SMCs, then assessed cell proliferation with tritiated thymidine. Overexpression of Smad3 enhanced whereas inhibition of Smad3 decreased cell proliferation. Conclusion: Differences in cellular composition and cell proliferation in conjunction with the finding that Smad3 is expressed exclusively in restenotic disease suggest that TGF-β, through Smad3 signaling, may play an essential role in SMC proliferation and the pathophysiology of restenosis in humans.

Original languageEnglish (US)
Pages (from-to)1289-1295
Number of pages7
JournalJournal of Vascular Surgery
Volume49
Issue number5
DOIs
StatePublished - May 2009

Fingerprint

Atherosclerotic Plaques
Femoral Artery
Smooth Muscle Myocytes
Cell Proliferation
Actins
Atherectomy
Peripheral Arterial Disease
Proliferating Cell Nuclear Antigen
Angioplasty
Thymidine
Small Interfering RNA
Transfection
Leukocytes
Macrophages
Genes

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery

Cite this

Characterization of primary and restenotic atherosclerotic plaque from the superficial femoral artery : Potential role of Smad3 in regulation of SMC proliferation. / Edlin, Rachel S.; Tsai, Shirling; Yamanouchi, Dai; Wang, Chunjie; Liu, Bo; Kent, K. Craig.

In: Journal of Vascular Surgery, Vol. 49, No. 5, 05.2009, p. 1289-1295.

Research output: Contribution to journalArticle

@article{b6c7f3199f03414a974e83fd9b15ec41,
title = "Characterization of primary and restenotic atherosclerotic plaque from the superficial femoral artery: Potential role of Smad3 in regulation of SMC proliferation",
abstract = "Objective: To characterize and compare primary and restenotic lesions of the superficial femoral artery and analyze the contribution of TGF-β/Smad3 signaling to the pathophysiology of peripheral artery occlusive disease. Methods and Results: Immunohistochemical studies were performed on specimens retrieved from the superficial femoral artery of patients undergoing either atherectomy for primary atherosclerotic or recurrent disease after stenting and/or prior angioplasty. Immunohistochemical analysis revealed a significantly higher smooth muscle cell (SMC) content (α-actin+) and expression of Smad3 in restenotic lesions while primary lesions contained significantly more leukocytes (CD45+) and macrophages (CD68+). Further studies demonstrated colocalization of Smad3 with α-actin and PCNA, suggesting a role for Smad3 in the proliferation observed in restenotic lesions. To confirm a role for Smad3 in SMC proliferation, we both upregulated Smad3 via adenoviral mediated gene transfer (AdSmad3) and inhibited Smad3 through transfection with siRNA in human aortic SMCs, then assessed cell proliferation with tritiated thymidine. Overexpression of Smad3 enhanced whereas inhibition of Smad3 decreased cell proliferation. Conclusion: Differences in cellular composition and cell proliferation in conjunction with the finding that Smad3 is expressed exclusively in restenotic disease suggest that TGF-β, through Smad3 signaling, may play an essential role in SMC proliferation and the pathophysiology of restenosis in humans.",
author = "Edlin, {Rachel S.} and Shirling Tsai and Dai Yamanouchi and Chunjie Wang and Bo Liu and Kent, {K. Craig}",
year = "2009",
month = "5",
doi = "10.1016/j.jvs.2008.11.096",
language = "English (US)",
volume = "49",
pages = "1289--1295",
journal = "Journal of Vascular Surgery",
issn = "0741-5214",
publisher = "Mosby Inc.",
number = "5",

}

TY - JOUR

T1 - Characterization of primary and restenotic atherosclerotic plaque from the superficial femoral artery

T2 - Potential role of Smad3 in regulation of SMC proliferation

AU - Edlin, Rachel S.

AU - Tsai, Shirling

AU - Yamanouchi, Dai

AU - Wang, Chunjie

AU - Liu, Bo

AU - Kent, K. Craig

PY - 2009/5

Y1 - 2009/5

N2 - Objective: To characterize and compare primary and restenotic lesions of the superficial femoral artery and analyze the contribution of TGF-β/Smad3 signaling to the pathophysiology of peripheral artery occlusive disease. Methods and Results: Immunohistochemical studies were performed on specimens retrieved from the superficial femoral artery of patients undergoing either atherectomy for primary atherosclerotic or recurrent disease after stenting and/or prior angioplasty. Immunohistochemical analysis revealed a significantly higher smooth muscle cell (SMC) content (α-actin+) and expression of Smad3 in restenotic lesions while primary lesions contained significantly more leukocytes (CD45+) and macrophages (CD68+). Further studies demonstrated colocalization of Smad3 with α-actin and PCNA, suggesting a role for Smad3 in the proliferation observed in restenotic lesions. To confirm a role for Smad3 in SMC proliferation, we both upregulated Smad3 via adenoviral mediated gene transfer (AdSmad3) and inhibited Smad3 through transfection with siRNA in human aortic SMCs, then assessed cell proliferation with tritiated thymidine. Overexpression of Smad3 enhanced whereas inhibition of Smad3 decreased cell proliferation. Conclusion: Differences in cellular composition and cell proliferation in conjunction with the finding that Smad3 is expressed exclusively in restenotic disease suggest that TGF-β, through Smad3 signaling, may play an essential role in SMC proliferation and the pathophysiology of restenosis in humans.

AB - Objective: To characterize and compare primary and restenotic lesions of the superficial femoral artery and analyze the contribution of TGF-β/Smad3 signaling to the pathophysiology of peripheral artery occlusive disease. Methods and Results: Immunohistochemical studies were performed on specimens retrieved from the superficial femoral artery of patients undergoing either atherectomy for primary atherosclerotic or recurrent disease after stenting and/or prior angioplasty. Immunohistochemical analysis revealed a significantly higher smooth muscle cell (SMC) content (α-actin+) and expression of Smad3 in restenotic lesions while primary lesions contained significantly more leukocytes (CD45+) and macrophages (CD68+). Further studies demonstrated colocalization of Smad3 with α-actin and PCNA, suggesting a role for Smad3 in the proliferation observed in restenotic lesions. To confirm a role for Smad3 in SMC proliferation, we both upregulated Smad3 via adenoviral mediated gene transfer (AdSmad3) and inhibited Smad3 through transfection with siRNA in human aortic SMCs, then assessed cell proliferation with tritiated thymidine. Overexpression of Smad3 enhanced whereas inhibition of Smad3 decreased cell proliferation. Conclusion: Differences in cellular composition and cell proliferation in conjunction with the finding that Smad3 is expressed exclusively in restenotic disease suggest that TGF-β, through Smad3 signaling, may play an essential role in SMC proliferation and the pathophysiology of restenosis in humans.

UR - http://www.scopus.com/inward/record.url?scp=65249093597&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65249093597&partnerID=8YFLogxK

U2 - 10.1016/j.jvs.2008.11.096

DO - 10.1016/j.jvs.2008.11.096

M3 - Article

VL - 49

SP - 1289

EP - 1295

JO - Journal of Vascular Surgery

JF - Journal of Vascular Surgery

SN - 0741-5214

IS - 5

ER -